LifeMD Inc (LFMD) - Total Assets
Based on the latest financial reports, LifeMD Inc (LFMD) holds total assets worth $70.41 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is LifeMD Inc's book value for net asset value and shareholders' equity analysis.
LifeMD Inc - Total Assets Trend (2011–2025)
This chart illustrates how LifeMD Inc's total assets have evolved over time, based on quarterly financial data.
LifeMD Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
LifeMD Inc's total assets of $70.41 Million consist of 73.6% current assets and 26.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 52.2% |
| Accounts Receivable | $9.31 Million | 13.2% |
| Inventory | $2.77 Million | 3.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $262.33K | 0.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how LifeMD Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see LifeMD Inc market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: LifeMD Inc's current assets represent 73.6% of total assets in 2025, an increase from 37.5% in 2011.
- Cash Position: Cash and equivalents constituted 52.2% of total assets in 2025, up from 9.8% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 13.2% of total assets.
LifeMD Inc Competitors by Total Assets
Key competitors of LifeMD Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Alcidion Group Ltd
AU:ALC
|
Australia | AU$115.63 Million |
|
DocCheck AG
XETRA:AJ91
|
Germany | €53.98 Million |
|
TRELLUS HEALTH LS -0006
F:85Q
|
Germany | €9.22 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$23.68 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
|
Oneview Healthcare Plc
AU:ONE
|
Australia | AU$15.49 Million |
LifeMD Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.25 | 0.81 | 1.16 |
| Quick Ratio | 1.18 | 0.76 | 1.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $10.26 Million | $-11.52 Million | $2.39 Million |
LifeMD Inc - Advanced Valuation Insights
This section examines the relationship between LifeMD Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 148.71 |
| Latest Market Cap to Assets Ratio | 2.69 |
| Asset Growth Rate (YoY) | -2.8% |
| Total Assets | $70.41 Million |
| Market Capitalization | $189.41 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values LifeMD Inc's assets at a significant premium (2.69x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: LifeMD Inc's assets decreased by 2.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for LifeMD Inc (2011–2025)
The table below shows the annual total assets of LifeMD Inc from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $70.41 Million | -2.83% |
| 2024-12-31 | $72.46 Million | +23.90% |
| 2023-12-31 | $58.48 Million | +127.85% |
| 2022-12-31 | $25.67 Million | -48.59% |
| 2021-12-31 | $49.92 Million | +272.48% |
| 2020-12-31 | $13.40 Million | +288.92% |
| 2019-12-31 | $3.45 Million | +31.73% |
| 2018-12-31 | $2.62 Million | +107.00% |
| 2017-12-31 | $1.26 Million | +60.01% |
| 2016-12-31 | $789.82K | +76.11% |
| 2015-12-31 | $448.47K | +155.95% |
| 2014-12-31 | $175.22K | -68.23% |
| 2013-12-31 | $551.45K | +49.16% |
| 2012-12-31 | $369.69K | +7.68% |
| 2011-12-31 | $343.33K | -- |
About LifeMD Inc
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature e… Read more